28 Nov 2025
London Spinouts: we are building space for you
Spinouts continue to grow as a mighty Asset Class
This month, spinouts have been everywhere, cropping up in reports, events, and the press.
No longer niche curiosities tucked away in university corridors, spinouts are emerging as a distinct asset class, blending academic credibility with commercial scalability.
Investors are beginning to treat spinouts not just as startups, but as a new category of investment, one that blends science, capital, and resilience. Across London, Europe, and beyond, spinouts are reshaping how we think about innovation and economic value creation.
Three reports released in November underline the growing strength of UK spinouts:
London’s Life Sciences: spinouts at the core
The MedCity Life Sciences Companies to Watch 2025 Report, released at London's Life Sciences Week, revealed a striking fact: 56% of the highlighted companies are spinouts.
This isn’t just a statistic, it’s a signal that Universities are proving to be fertile ground for commercial breakthroughs, particularly in life sciences, and spinouts are also a dominant share of London’s innovation pipeline.
Additionally:
56% are spinouts: a dominant share of London’s innovation pipeline.
The Knowledge Quarter & White City are where the majority are based
Commercial traction: spinouts are attracting capital faster than traditional startups.
Spinouts are not just participating in London’s Life Sciences ecosystem; they are defining it.
Deep Tech 2025: spinouts as a superpower
The Dealroom Deep Tech Report 2025 , in partnership with the Royal Academy of Engineering, dedicates an entire chapter to spinouts, and makes some striking points. Spinouts are not just numerous, they’re disproportionately valuable. While they account for 34% of deep tech startups, they represent 37% of total enterprise value, punching above their weight in terms of economic impact.
Additionally:
They make up 43% of the startups that raised $10 million+ funding.
 Photonics (64% spinouts) and Quantum (58% spinouts) are the deep tech sectors with the strongest academic ties..
Switzerland & UK dominate Europe’s spinout ranking
The Dealroom European Spinouts Report 2025Â reveals staggering numbers: deep tech and life sciences spinouts across Europe are valued at $398 billion, creating over 167,000 jobs.
Additionally:
 UK universities (Oxford and Cambridge) claim the two top spots with three others in the top ten (UCL, Imperial and University of Bristol). Switzerland has three locations in the top 10.
Value creation by spinouts is accelerating
The UK leads for spinout value creation, followed by Germany, Switzerland and France
Sciopolis: building the workspace London spinouts need
At Sciopolis, we believe spinouts deserve more than recognition, they need space to scale and develop their ideas.
That’s why we are building cost‑effective, ready‑to‑occupy lab and office spaces in London at One Portal Way, in partnership with Imperial - and soon in other locations.
But this isn’t just about (or for) Imperial spinouts. We want the best biotech, quantum, cleantech, AI spinouts from across London’s universities — UCL, King’s, Queen Mary, Brunel and beyond — to come together in our hubs.
By clustering talent, ideas, and capital in shared spaces, we are going to create an environment where spinouts can collaborate, accelerate and ultimately scale.
Now is the time to act. If you’re building a spinout, or supporting one, or want to invest in the next cohort of exciting spinouts - join us at One Portal Way - opening in June 2026